Jerusalem, Israel

Daniel Sherman

USPTO Granted Patents = 1 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Sherman

Introduction

Daniel Sherman is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can aid in the treatment of various diseases. His work is characterized by a focus on innovative solutions that address critical health issues.

Latest Patents

Daniel Sherman holds a patent for "Sulfonamides for the modulation of PKM2." This invention relates to sulfonamide compounds and methods for activating PKM2. The compounds and methods developed by Sherman are useful in treating or preventing diseases or disorders such as cancer, cell proliferative disorders, inflammatory disorders, metabolic disorders, and immune system disorders. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Sherman is currently employed at Dynamix Pharmaceuticals Ltd., where he continues to innovate and develop new therapeutic solutions. His work at Dynamix Pharmaceuticals Ltd. allows him to collaborate with other talented professionals in the field, further enhancing the impact of his inventions.

Collaborations

Some of his notable coworkers include Oren Becker and Alina Shitrit. Their collaborative efforts contribute to the dynamic environment at Dynamix Pharmaceuticals Ltd., fostering innovation and the development of groundbreaking treatments.

Conclusion

Daniel Sherman exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the area of sulfonamide compounds, highlight the potential for scientific advancements to improve health outcomes. His work continues to inspire future innovations in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…